These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 888491)

  • 1. [Treatment of various forms of icterus or cholestasis with phenobarbital (author's transl)].
    Stiehl A
    Z Gastroenterol; 1977 Jun; 15(6):404-16. PubMed ID: 888491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Congenital nonhemolytic hyperbilirubinemias].
    Wehinger H
    Med Klin; 1977 Sep; 72(37):1463-72. PubMed ID: 409916
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and diagnostic value of determining bile pigments].
    Tsirkina AS
    Lab Delo; 1984; (9):569-71. PubMed ID: 6210416
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatic-cell enzyme induction using phenobarbital: applications to the treatment of jaundice].
    Nusinovici V; Darnis F; Levy VG; Caroli J
    Sem Hop Ther; 1976 Mar; 52(3):171-4. PubMed ID: 795031
    [No Abstract]   [Full Text] [Related]  

  • 5. [Phenobarbital in the treatment of hepatic disorders of bilirubin metabolism].
    Gonciarz Z; Czarnecka K
    Pol Tyg Lek; 1979 May; 34(22):883-6. PubMed ID: 384377
    [No Abstract]   [Full Text] [Related]  

  • 6. Neonatal Dubin-Johnson syndrome with severe cholestasis: effective phenobarbital therapy.
    Kimura A; Ushijima K; Kage M; Mahara R; Tohma M; Inokuchi T; Shibao K; Tanaka N; Fujisawa T; Ono E
    Acta Paediatr Scand; 1991 Mar; 80(3):381-5. PubMed ID: 2035335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Editorial: Liver diseases in childhood 2nd part].
    Schock-Leber
    Padiatr Padol; 1975; 10(4):301-314. PubMed ID: 1215065
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathogenesis of different types of jaundice.
    Arias JM
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():2029-39. PubMed ID: 1030162
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of phenobarbital on serum and biliary parameters in a patient with Crigler-Najjar syndrome, type II and acquired cholestasis.
    Trotman BW; Shaw L; Roy-Chowdhury J; Malet PF; Rosato EF
    Dig Dis Sci; 1983 Aug; 28(8):753-62. PubMed ID: 6872808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barbituates and biliary function.
    Capron JP; Erlinger S
    Digestion; 1975; 12(1):43-56. PubMed ID: 126185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Liver metabolism of drugs (author's transl)].
    Darnis F
    MMW Munch Med Wochenschr; 1976 Jun; 118(25):805-10. PubMed ID: 59311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful photo-and phenobarbital therapy during pregnancy in a woman with Crigler-Najjar syndrome type II.
    Holstein A; Plaschke A; Lohse P; Egberts EH
    Scand J Gastroenterol; 2005 Sep; 40(9):1124-6. PubMed ID: 16211719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsiveness to phenobarbital in an adult with Crigler-Najjar disease associated with neurological involvement and skin hyperextensibility.
    Persico M; Romano M; Muraca M; Gentile S
    Hepatology; 1991 Feb; 13(2):213-5. PubMed ID: 1899849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of phenobarbital on the intrahepatic metabolism of bilirubin].
    Oleĭnik AN
    Klin Med (Mosk); 1978 Feb; 56(2):27-33. PubMed ID: 416290
    [No Abstract]   [Full Text] [Related]  

  • 15. The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease.
    Luketic VA; Sanyal AJ
    Gastroenterologist; 1994 Mar; 2(1):74-9. PubMed ID: 8055235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gilbert's jaundice. Current clinico-nosographic, physiopathological and therapeutic aspects. III. Therapeutic action of enzyme inductors with reference to unconjugated bilirubin icterus].
    Lovisetto P; Giorcelli W; Actis GC; Biarese V
    Minerva Med; 1977 Jan; 68(2):73-81. PubMed ID: 834386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phenobarbital in Crigler-Najjar syndrome type 1: A therapeutic option].
    Rubio Gómez I; López González MF; Ibáñez Alcalde MM; Cañabate Reche F
    An Pediatr (Barc); 2016 Aug; 85(2):115-116. PubMed ID: 27134052
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hyperbilirubinemia in liver diseases].
    Stiehl A
    Fortschr Med; 1982 May; 100(18):842-5. PubMed ID: 6807787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of Crigler-Najjar's congenital familial non-hemolytic jaundice with kernicterus].
    Plöchl E; Hohenwallner W
    Wien Med Wochenschr; 1978 Feb; 128(3):70-3. PubMed ID: 75612
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of phenobarbital in a case of extrahepatic cholestasis.
    Metreau JM; Bismuth H; Franco D; Dhumeaux D
    Gastroenterology; 1975 Mar; 68(3):567-71. PubMed ID: 1112459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.